Immunitybio Inc (IBRX): Kapitalflussrechnung
Kennzahl in 1000 USD | TTM 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Umsatz | 165.792 | 113.288 | 14.745 | 622 | 240 | 934 | 605 | 43 | 47 | 45 | 44 | 236 | 641 | 600 |
Cashflow aus operativer Geschäftstätigkeit | -356.497 | -304.936 | -391.236 | -366.757 | -337.509 | -274.419 | -171.724 | -152.109 | -63.381 | -48.780 | -38.593 | -25.305 | -5.354 | -668 |
▸ Operative Cashflow Marge | -215,03% | -269,17% | -2.653,35% | -58.964,15% | -140.628,75% | -29.381,05% | -28.384,13% | -353.741,86% | -134.853,19% | -108.400% | -87.711,36% | -10.722,46% | -835,26% | -111,33% |
Investitionsausgaben (CapEx) | 9.129 | 3.846 | 6.888 | 30.584 | 78.162 | 33.563 | 1.669 | 4.287 | 13.102 | 34.815 | 6.560 | 2.241 | 299 | 3 |
Cashflow aus Investitionstätigkeit | -308.557 | -149.801 | -12.246 | -30.470 | 27.297 | -84.886 | -19.812 | 18.552 | 57.101 | 99.552 | -113.672 | -175.224 | -299 | -3 |
Cashflow aus Finanzierungstätigkeit | 720.708 | 400.241 | 281.630 | 558.341 | 233.613 | 505.443 | 150.675 | 114.279 | -771 | -34.983 | -15.560 | 317.333 | 64.407 | 905 |
Freier Cashflow | -365.626 | -308.782 | -398.124 | -397.341 | -415.671 | -307.982 | -173.393 | -156.396 | -76.483 | -83.595 | -45.153 | -27.546 | -5.653 | -671 |
▸ Freie Cashflow Marge | -220,53% | -272,56% | -2.700,06% | -63.881,19% | -173.196,25% | -32.974,52% | -28.660% | -363.711,63% | -162.729,79% | -185.766,67% | -102.620,45% | -11.672,03% | -881,9% | -111,83% |
Ausgeschüttete Dividenden | - | - | - | - | -616 | -334.436 | -4.444 | -2.276 | - | - | - | - | - | - |
Neuausgabe und Rückkäufe von Stammaktien | - | - | - | -3.443 | -616 | -4.064 | -503 | -2.501 | -228 | -15.227 | -15.847 | -4.798 | - | - |
Kennzahlen dieser Seite im Lexikon
Weitere Informationen findest du im Takani-Lexikon.